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Abstract IgE-mediated food allergy is a relevant health problem
inducing symptoms ranging from mild local reactions up to se-
vere life-threatening situations. Currently, no immunotherapy is
available and avoidance of the incriminating food is the method
of choice. Therefore, reliable diagnostic tools to formulate dietary
recommendations and to avoid unnecessary exclusion diets for
the individual patient are urgently needed. This review provides
an update on the current knowledge on food allergens and their
application in various diagnostic approaches such as skin prick
test, basophil activation test, and serum IgE testing. Furthermore,
these new approaches are discussed and compared to convention-
al extract-based assays and correlated to the gold standard of food
allergy diagnosis, the double-blind placebo-controlled food chal-
lenge. Finally, the application of food allergens for preventive
measurements such as allergen detection assays and the determi-
nation of threshold levels for allergen levels are discussed.
Keywords Allergens . Allergy diagnosis .
Component-resolved diagnosis . Food allergy . IgE
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Introduction
Allergic diseases are regarded as a relevant global burden to
society and healthcare systems. The prevalence for asthma,
allergic rhinitis, and atopic eczema has indeed increased in
the recent past. However, for IgE-mediated food allergy, the
picture is less clear. A recent systematic review and meta-
analysis of food allergy in Europe identified a 17.3 % pooled
lifetime prevalence of self-reported food allergy and a point
prevalence of 5.9 % [1, 2]. In contrast, the point prevalence of
food allergy (FA) diagnosis based on food challenges was
around 0.9 %, yet differing on the food allergen source and
depending on the age. While for diagnosis of food allergy,
double-blind placebo-controlled food challenge (DBPCFC)
is regarded as the gold standard; a careful case history is
equally mandatory. The detection of allergen-specific IgE an-
tibodies completes the state-of-the-art diagnosis of food aller-
gy [3]. Besides symptomatic treatment, there is no causative
immunotherapy available. Currently, avoiding the causative
allergen sources is the method of choice.
In food allergy, two different routes of sensitization are
known. While in primary food allergy, the atopic individual
becomes sensitized against the culprit dietary protein through
the gastrointestinal tract, and in secondary food allergy, sensiti-
zation occurs via pollen or latex allergens and the allergic reac-
tion is induced by cross-reactive homologous food allergens [4].
The diagnostic relevance of specific IgE testing strongly
depends on the quality of the analyte used. For more than
100 years, total extracts obtained from allergen sources were
used. It is well known that these extracts are not very well
standardized and may lack certain allergens, e.g., due to en-
zymatic activity [3].
During the past 25 years, a plethora of individual allergens has
been identified and their physicochemical properties analyzed.
Especially, up-to-date molecular biology methods facilitated the
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production of recombinant allergens for in vitro diagnosis. The
determination of specific IgE to different allergens is called mo-
lecular diagnosis or component-resolved diagnosis (CRD).
Molecular diagnosis will help to increase the sensitivity of
the testing and, on the other hand, provides a more-detailed
patient-tailored risk profile. This in turn can help to formulate
improved dietary recommendations and reduce unnecessary
exclusion diets [3].
However, it has to be stated that most allergens described in
CRD studies so far have been applied in experimental settings.
Therefore, the recent EAACI Guidelines on the Diagnosis and
Management of Food Allergy clearly emphasized the urgent
need for well-designed randomized controlled studies to as-
sess the diagnostic value of CRD-based tests [3].
Allergen Extract Versus Single Allergens
Production and Purification of Allergens for Molecular
Diagnosis
Allergens used for CRD can be obtained from either natural
sources or expressed in heterologous expression systems. The
decision whether to purify natural or recombinant allergens
has to be made on a case-by-case approach and depends on a
number of aspects. For example, the presence and impact of
any post translational modification on the IgE binding activity
of the target protein need to be evaluated throughout the puri-
fication process. If a given allergen consists of a number of
isoforms all relevant for allergy diagnosis, then the natural mix
of proteins is to be preferred. In contrast, if one isoform is
representative for IgE-based diagnosis, then the recombinant
production can be chosen. Similarly, if the natural protein is
sensitive to enzymatic degradation during the extraction pro-
cess, then heterologous expression systems can be advanta-
geous. If the correct three-dimensional structure of the protein
is crucial for the known interaction with IgE antibodies, then
either suitable expression systems or purification from natural
sources can be chosen [5, 6]. Equally important is the devel-
opment of a suitable purification protocol of the allergen of
interest. Finally, the protein has to be tested for its physico-
chemical properties such as stability, purity, correct primary,
secondary, and tertiary structure, enzymatic activity, and IgE
binding capacity [7, 6]. As a proof of concept, an allergen
library was developed within the EU-funded project
EuroPrevall, collecting highly pure and well-characterized
food allergens from the most important food allergen sources.
Up to date, the integrity of the purified allergen batches was
assessed by technologies such as HPLC, mass spectrometry,
and infrared spectroscopy. CD spectroscopy and 1D-NMR can
be applied to analyze the secondary structure of allergens [8].
As stated above, a considerable number of allergens have
been identified from animal- and plant-derived foods.
Consecutively, a number of allergen databases were
established to collect and update the existing data on allergens,
their physicochemical features, and allergenic relevance. The
IUIS allergen database (http://www.allergen.org) is the official
source, providing a systematic nomenclature for allergens,
taking care of identification of allergens, and upon positive
evaluation of the allergen nomenclature subcommittee, the
official allergen designation is granted [9, 10]. The
Allergome database (http://www.allergome.org) is a
continuously updated non-peer-reviewed literature collection
about all aspects of allergens, while the AllergenOnline
(http://www.allergenonline.org) provides peer-reviewed infor-
mation about allergens and sequence comparison tools for
allergenic risk assessment. SDAP, the structural database of
allergens, collects all the known structures of allergens (http://
fermi.utmb.edu/SDAP/index.html), while others such as the
InformAll link clinical data with allergens (http://www.
inflammation-repair.manchester.ac.uk/informAll/).
Analyzing all the existing allergen sequences, it became ev-
ident that only a minority of all known protein families contain
intrinsic properties that render them allergenic [11–13].
Tests for Food Allergy Diagnosis
In the following, the application of allergen-specific testing for
food allergy diagnosis will be discussed. Furthermore, an
overview on the most important plant-derived food allergen
sources and their respective allergen panels will be presented.
Skin Prick Testing
In vivo skin prick testing for food allergy diagnosis is rou-
tinely performed. The food extracts used for skin prick test-
ing (SPT) are not all standardized and may vary from batch
to batch missing some allergens [14–16]. Therefore, prick-
to-prick testing with the food source is applied in daily prac-
tice, especially when testing plant food allergen sources
(fresh fruits, vegetables, nuts).
In proof-of-concept studies, purified recombinant fruit al-
lergens from apple and peach were tested in SPTs. Bolhaar
and colleagues applied purified recombinant apple allergen
Mal d 1, the Bet v 1 homologue, by SPT in 14 patients using
serial dilutions ranging from 0.02, 0.2, 2, 20, to 100 μg/mL.
Positive skin reactions were observed in a dose-dependent
manner starting with the lowest concentration of 2 μg/mL
[17]. In a similar study, purified recombinant Mal d 4, the
apple profilin, was tested in 5 patients in the same serial
dilutions 0.02, 0.2, 2, 20, and 100 μg/mL, giving positive
reactions at a the dose of 0.2 μg/mL [18].
Garcia et al. performed SPTs with four peach extracts con-
taining 0.4, 2, 10, and 50 μg/mL of Pru p 3, the non-specific
lipid transfer protein (nsLTP) from peach [19], during a
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sublingual immunotherapy trial with natural Pru p 3. They
showed that after 6 months of SLIT, the active group present-
ed a significant decrease (5.3 times) in SPTs, which correlated
with a significant increased tolerance of peach intake [19].
In a recent study, Kollmann et al. used purified recombi-
nant Mal d 1 and Bet v 1 (birch pollen allergen) and birch
pollen extract (BPE) in SPTs [20•]. For this study, the recom-
binant allergen was produced under goodmanufacturing prac-
tice (GMP) conditions suitable for clinical trials. Twenty out
of 21 patients had a positive reaction to rMal d 1 (50 μg/mL)
and to fresh apple. The overall sensitivity of the SPTwas 95%
for rMal d 1 [20•].
There are not yet purified recombinant allergens approved
for SPTs in clinical routine, while for some European coun-
tries, purified natural peach nsLTP (Pru p 3) and purified nat-
ural date profilin can be used [21].
Peeters and colleagues applied purified natural peanut al-
lergens, Ara h 1, Ara h 2, Ara h 3, and Ara h 6, in SPTs in a
collective of 30 peanut-allergic patients in serial dilutions
ranging from 100 μg/mL down to 0.01 μg/mL [22]. The ma-
jority of the patients with severe reactions to peanuts had
positive SPTs to Ara h 2 and Ara h 6, even at low concentra-
tions. However, SPT reactions to Ara h 1 and Ara h 3, at
higher concentrations, were also indicative for severe reac-
tions [22]. In a pediatric study, the same set of natural peanut
allergens was used for SPTs and provided a similar reactivity
pattern as in the adult study group, with Ara h 2 and Ara h 6
inducing in most of the patients a positive reaction, while this
was less pronounced for Ara h 1 and Ara h 3, respectively
[23]. However, positive allergen-specific SPTs could not be
related to the severity of peanut allergy.
Serum IgE Testing
Extract-based in vitro testing for specific IgE antibodies has
been used for a long time and is still in use for routine diag-
nosis. In the past three decades, advanced molecular biology
methods enabled a dramatic increase in our knowledge on
individual allergens and their potential application in diagno-
sis and therapy. The application of individual purified aller-
gens for in vitro diagnosis has been designated molecular
diagnosis or CRD.
One application of purified, well-characterized allergens is
their use as a certified reference material for existing and ap-
proved in vitro diagnostics. The EuropeanUnion (EU)-funded
project CREATE used well-defined inhalant allergens and
provided a proof-of-concept study to improve standardization
of existing extract-based diagnostics [24]. However, while this
has been shown for inhalant allergies, no such tools are avail-
able for food allergy to date. One option is to spike a given
food extract with one or several individual allergens. So far,
only one example has entered the market, namely Cor a 1.04,
the Bet v 1 homologous food allergen from hazelnut, which
was added to hazelnut extract for improved in vitro diagnosis
[25]. While the Cor a 1.04-specific IgE antibody detection
improved upon spiking, no assay interference due to the spik-
ing event was observed for the other allergens present in the
hazelnut extract. In a clinical study, the results obtained with
spiked hazelnut extract for specific IgE antibodies were com-
pared with DBPCFCs in hazelnut-allergic children [26].
While the negative predictive value of in vitro diagnosis was
improved with the spiked hazelnut extract, the positive pre-
dictive value was rather moderate to decreased [26].
Recently, CRD for hazelnut and peanut allergy was com-
pared to the outcome of DBPCFCs. For peanut allergy, Eller
and Bindslev-Jensen identified anti-Ara h 2 IgE >1.63 kU/L
as a clear decision point with both optimal specificity and
high sensitivity to predict clinically relevant peanut allergy
[27••]. In addition, applying this cutoff value, the number of
necessary DBPCFCs could be significantly reduced. In con-
trast, Beyer and co-authors identified 14.4 kU/L anti-Ara h 2
IgE to be 90 % predictive for a positive peanut challenge
[28••]. For hazelnut positive challenge outcome, these au-
thors calculated Cor a 14-specific IgE at 47.8 kU/L to be
90 % predictive [28••].
Basophil Activation Test
Cellular tests are available to verify the presence of
allergen-specific IgE in patients’ sera and the ability to
activate basophils. These tests either use autologous cells
from the donor or established cell lines. After passive sen-
sitization with serum and the addition of allergen extracts
or allergens, cell activation can be measured by the deter-
mination of histamine or sulfidoleukotriene release. Alter-
natively, expression of a surface marker such as CD63 or
CD203c is detected by fluorescence-activated cell sorting
(FACS) analysis. CD63, a glycoprotein, is present only in
low levels in resting basophils. However, upon activation, it
is upregulated. Similarly, CD203c, an ecto-enzyme, is
expressed on the cell membrane of human basophils and
mast cells and becomes upregulated upon cross-linking of
the Fc-epsilon receptor alpha. Erdmann and co-authors test-
ed sera from 32 patients with Bet v 1-related plant food
allergies. The recombinant allergens Api g 1 from celery,
Dau c 1 from carrot, and Mal d 1 from apple were applied
in the basophil activation test (BAT) assay, and CD63 up-
regulation was determined by FACS analysis. In this study,
sensitivity for BAT ranged from 65 to 75 % and specificity
from 68 to 100 % [29].
Sato and co-workers evaluated the CD203c expression on
basophils from 71 egg- and milk-allergic children in the BAT
assay [30]. In parallel, egg extract and Gal d 1, ovomucoid, and
cow’s milk extract and Bos d 8, casein, were applied. The
authors determined the CD203c stimulation index and the
threshold of CD203c expression. In their study population, they
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found no difference in sensitivity, specificity, and positive pre-
dictive values (PPV), when comparing milk extract to Bos d 8.
In hen’s egg allergy, sensitivity, specificity, and PPV for Gal d 1
were superior as compared to those in hen’s egg extract [30].
Similar studies were also performed in peanut-allergic
children. Glaumann and co-authors evaluated the basophil
allergen threshold sensitivity, called CD-sens, and peanut
allergen-specific IgE antibody levels in relation to DBPCFC
outcome [31•]. Basophil tests were performed with both
peanut extract and purified rAra h 2 and yielded positive
results in 92 % of the tested samples and were in agreement
with a positive DBPCFC. Negative outcome in CD-sens was
paralleled by negative results in DBPCFCs. Finally, specific
IgE raised against Ara h 1, Ara h 2, and Ara h 3 was clearly
associated with peanut allergy [31•].
Santos and co-workers compared the threshold of allergic
reactions to peanuts with peanut extract basophil reactivity
and identified clear associations [32].
For milk allergy, CRD was performed in milk-allergic pa-
tients and compared to the outcome of the basophil degranu-
lation tests [33]. Despite specific IgE directed against milk
allergens, the basophil degranulation test could discriminate
between milk-allergic patients and patients still sensitized but
that had already outgrown. Ford and co-workers performed
another study, including milk-allergic children and assessed,
whether they had already acquired tolerance by specific IgE
testing and BAT assays using baked milk antigens. Again, the
results from the BAT test proved useful in the identification of
different phenotypes of the patients [34].
Food Allergen Panels for CRD
For some foods, a range of allergens are available for CRD,
while for others, only single allergens have been identified to
date. In the recent past, efforts were undertaken to perform
CRD studies in well-characterized patients with positive
DBPCFCs. These studies contribute to compile a patient-
tailored risk profile and allow to relate distinct sensitization
patterns with either mild or severe and/or generalized symp-
toms. They also allow to identify cross-sensitizations such as
pollen allergens and help to discriminate between primary and
secondary food allergy. In addition, these studies provide use-
ful information about the sensitivity and specificity of these
allergen-specific IgE testing. In the following, the selected
examples of plant food allergen panels which are summarized
in Table 1 will be briefly discussed.
Apple and Peach
Recent prevalence data for fruit allergies identified peach and
apple as the most frequent sensitizers in Europe [35]. Four
allergens have been officially designated for apple. These
proteins were applied for CRD studies in the SAFE study.
The Bet v 1 homologue, Mal d 1, was the major allergen in
Central Europe (Netherlands, Austria) and linkedwith Fagales
pollen allergy. In contrast, sensitization to the nsLTP, Mal d 3,
was frequent in Southern Europe (Spain, Italy) and linked
with severe allergic symptoms [36]. Sensitization to profilin,
Mal d 4, is evenly distributed across Europe, associated most-
ly with grass and tree pollen allergy. For the thaumatin-like
protein, Mal d 2, the dataset is less clear.
Peach allergy is dominant in Southern Europe and corre-
lates with high consumption rates of fresh fruits throughout
the year. Pru p 3, the nsLTP, is the major allergen in clinically
relevant peach allergy [37] and accumulates in the peach peel.
Boyano-Martinez assessed a high Pru p 3 sensitization rate in
children and confirmed that the majority of the patients toler-
ated peach pulp [38••]. Sensitization to Pru p 3 starts earlier in
life as compared to Pru p 1 and Pru p 4, the Bet v 1 homologue
and the profilin, respectively [39].
Kiwifruit
The number of kiwifruit-allergic patients has remarkably in-
creased in the last two decades, and the actual prevalence rate
of sensitization in Europe is 5.2 % [35]. Since the extract-
based IgE tests were of low sensitivity, efforts were under-
taken to apply the existing kiwifruit allergen panel for CRD.
Bublin and co-workers tested 237 sera from kiwifruit-allergic
patients in the microarray format. The panel of allergens
showed a diagnostic sensitivity of 66 %, a specificity of
56 %, and a positive predictive value of 73 % [40]. Actinidin,
Act d 1, from kiwifruit is regarded as a marker for kiwifruit
monosensitization and linked with generalized symptoms. In
contrast, pollen-related kiwifruit allergy correlates with sen-
sitization to the Bet v 1 homologue and profilin, Act d 8 and
Act d 9, respectively [41]. Testing the large panel of different
kiwifruit allergens showed that some allergens sensitize only
in rare cases and may be specific for certain geographic area,
such as Act d 6 [40]. In a European study, 311 sera from
kiwifruit-allergic patients were tested. Comparing different
geographic regions, sensitization to Act d 9, the kiwifruit
nsLTP, was predominant for Southern Europe [42••]. Act d
1 was identified as a marker for severe symptoms upon ki-
wifruit consumption.
Vegetables
Celery is a frequent cause for food allergic reactions, especial-
ly in Europe with a sensitization prevalence of 6.3 % [35].
Food allergic symptoms can range from mild local reactions,
usually restricted to the oral mucosa, up to severe anaphylactic
reactions. Sensitization to the pollen-related allergens Api g 1,
the birch pollen homologue, and Api g 4, the profilin, are
usually found in patients with concomitant tree pollen allergy
56 Page 4 of 8 Curr Allergy Asthma Rep (2015) 15: 56
and account for rather mild symptoms. Api g 5 is a flavin
adenine dinucleotide (FAD) containing oxidase and con-
tains N-glycans, which account for the majority of its IgE
binding capacity [43]. Api g 2 and Api g 6 are both
nsLTPs, differently expressed throughout the plant tissue
[44, 45]. So far, little is known about their relevance as
major or minor allergens. However, it seems that the cele-
riac allergen panel is still incomplete; a marker allergen
responsible for the mugwort–celery cross-reactivity, usually
known to be linked with severe symptoms in allergic pa-
tients, is especially missing.
In parallel, carrot allergy is predominant in areas where
Fagales pollen exposure is abundant. This cross-reactivity is
due to the Bet v 1 homologue, Dau c 1, and the profilin,
Dau c 4 [46••]. The diagnostic relevance of additional carrot
allergens, such as Dau c 5, the isoflavone reductase, is not
yet determined.
Tree Nuts
Among tree nuts, hazelnuts are a common source of food aller-
gies, with and without concomitant pollen allergy with an over-
all sensitization prevalence of 9.3 % in Europe [35]. Hansen
and co-authors investigated the sensitization profiles from 52
hazelnut-allergic patients from Denmark, Switzerland, and
Spain [47]. While the Bet v 1 homologue, Cor a 1.04, was
predominant in Northern and Central Europe, the sensitization
to Cor a 8, the nsLTP from hazelnut, dominated in Spain.
Profilin, Cor a 2, sensitization was evenly distributed in all
countries (40–45 %). Only in 2 % sensitization to Cor a 11
was detected. Masthoff et al. investigated a total of 161
hazelnut-allergic patients, including children and adults, and
identified sensitization to Cor a 14, the 2S albumin, and Cor a
9, the 11S globulin, as a marker for rather severe allergy symp-
toms [48••]. In a recent European study, Datema et al. used 7
hazelnut allergens to test sera from 423 hazelnut-allergic pa-
tients [49••]. IgE levels against Cor a 1 were the highest ones as
compared to other hazelnut allergens. Cor a 8 sensitization was
dominant in Greece and Spain. Cor a 14 sensitization was high-
ly correlated with sensitization to Cor a 9. Cor a 11 sensitization
was generally low, in all study centers. However, sensitization
to Cor a 12, the oleosin from hazelnut, was detected in 10–25%
of the patients in most of the centers. Interestingly, sensitization
to seed storage proteins and oleosins correlated with sensitiza-
tion to other nuts, seeds, and pollens [49••].
Peanuts
Peanut is known as a highly allergenic food, tentatively induc-
ing severe, even life-threatening symptoms. In some patients,
Table 1 Selected studies on allergen panels used for CRD in plant food allergies




Mal d 1, Mal d 2, Mal d 3, Mal d 4 389 apple-allergic patients (AT, NL, ES, IT) Fernandez-Rivas et al. 2003 [36]
Peach (Prunus
persica)
Pru p 1, Pru p 3, Pru p 4 76 peach-allergic adult patients (ES) Fernandez-Rivas et al. 2003 [37];
57 peach-allergic pediatric patients (ES) Boyano-Martinez et al. 2013 [38••]
148 peach-allergic adolescent/adult patients (IT) Pastorello et al. 2013 [39]
Kiwifruit (Actinidia
deliciosa)
Act d 1, Act d 2, Act d 4,
Act d 5, Act d 6, Act d 7,
Act d 8, Act d 9, Act d 11
92 kiwifruit-allergic patients Palacin et al. 2008 [59]
30 kiwifruit-allergic patients (CH) Bublin et al. 2013 [41]
311 kiwifruit-allergic patients (EU-wide study) Le et al. 2013 [42••]a
Vegetables
Carrot (Daucus carota) Dau c 1, Dau c 4, Dau c 5 49 carrot-allergic patients (DK, CH, ES) Ballmer-Weber et al. 2012 [46••]
Celery (Apium
graveolens)




Cor a 1, Cor a 2, Cor a 8,
Cor a 9, Cor a 11,
Cor a 12, Cor a 14
52 hazelnut-allergic patients (DK, CH, ES) Hansen et al. 2009 [47]
161 hazelnut-allergic patients (NL) Masthoff et al. 2013 [48••]




Ara h 1, Ara h 2, Ara h 3, Ara h 6,
Ara h 8, Ara h 9
Population-based birth cohort study; 933
children; (UK) 150 peanut-allergic
patients (adults; EU-wide study)
Nicolaou et al. 2010 [51••]
Ballmer-Weber et al. 2015 [57•]
The selected studies performed at least in a subset of patients DBPCFCs or open challenges for diagnosis of food allergy
a Outpatient clinic study: no challenges were performed
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even minute amounts of peanuts can induce allergic reactions.
Therefore, improved in vitro diagnosis could help to reduce
the number of DBPCFCs and help to determine individual
threshold levels for the high-risk patients. Burney and co-
authors identified a sensitization prevalence of 2.7 % [35],
yet the prevalence of clinical relevant peanut allergy is expect-
ed to be around 1 % [50]. In order to get a deeper insight into
actual population-based data on peanut allergy, Nicolaou and
co-workers investigated the prevalence of peanut allergy ver-
sus tolerance in children at the age of 8 years (total 933 par-
ticipants) [51••]. The sensitization profiles were assessed
using peanut allergens, Ara h 1, Ara h 2, Ara h 3, and Ara h
8, and SPTs were performed with peanut extract. Within this
collective, 11.8 % had specific IgE to at least one of the peanut
allergens. However, only 22.4 % out of the sensitized individ-
uals had a clinically relevant peanut allergy, as assessed by
DBPCFCs. When correlating the sensitization profiles with
the DBPCFC results, Ara h 2, the 2S albumin from peanut,
was the best predictor for clinical peanut allergy. Since then, a
number of studies confirmed the relevance of Ara h 2 as a
predictor for peanut allergy in both pediatric and adult study
groups [52, 53•, 27••, 28••]. When Ara h 6, another 2S albu-
min from peanut, became available for molecular diagnosis, it
was found to be an equally important predictor for peanut
allergy [54•, 55]. Specific IgE directed against Ara h 1, the
7S globulin, and Ara h 3, 11S globulin from peanut, are addi-
tional relevant markers for peanut allergy [56, 57•]. A recent
European study analyzed the sensitization patterns of peanut
allergy patients and confirmed the predictive value of spIgE
against Ara h 2. Sensitization to Ara h 8 (Bet v 1 homologue)
and Ara h 9 (nsLTP) was observed in different geographical
regions and was more frequently found in peanut-tolerant sub-
jects. Sensitization to Ara h 1 and Ara h 2 was exclusively
observed in early onset of peanut allergy [57•].
Purified Food Allergens for Food Safety Aspects
In order to protect the allergic consumer from unintended
exposure to allergenic food, legislation on allergen labeling
has been set in place in many countries across the world.
Consecutively, food industry has started initiatives to dissem-
inate best practices for allergenic risk assessment and manage-
ment among food producers. However, to implement risk as-
sessment strategies during food production, processing, and
packaging, reliable allergen detection assays and certified ref-
erence materials are still lacking. In addition, an agreed defi-
nition of a tolerable allergenic risk including threshold levels
for each allergenic food is not yet in place [58]. For all these
preventive measurements, purified well-defined food aller-
gens can be used, and by replacing total extracts or spiking,
total extracts with individual allergen test systems could be
improved and provide more accurate determinations.
Conclusions
In the last two decades, our knowledge on individual allergens
has dramatically increased. As a consequence, the application
of well-definedmolecules for in vitro diagnosis was started for
the most important food allergen sources. While for some
foods, the allergen panels are considerable complex, and for
others, only a few allergens are identified yet. Nevertheless, it
became evident that molecular diagnosis provides additional
information as compared to conventional extract-based test-
ing. It enables to identify cross-sensitization to inhalant aller-
gen sources such as pollens. Furthermore, for some allergens,
it emerged that they predominantly evoke mild allergic symp-
toms, while for others, they are inducers for severe symptoms.
Nevertheless, these molecular diagnosis approach needs to be
assessed on a food-by-food approach and the sensitivity and
specificity of this test has to be compared to the conventional
diagnostic tests, including the DBPCFCs. Therefore, more
clinical studies are needed for assessing the relevance of mo-
lecular diagnosis for each food allergen source.
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